US Futures rebounding, watch AAPL, GILD, BA
Jean-Christophe Rolland June 29, 2020 10:07 PM
The S&P 500 Futures are rebounding after Friday sharp decline.
The S&P 500 Futures are rebounding after Friday sharp decline as indices were dragged down by financial stocks which were market leaders in the prior session. The Dow Jones Industrial Average plunged 730 points (-2.84%) to 25015, the S&P 500 sank 74 points (-2.42%) to 3009, and the Nasdaq 100 was down 252 points (-2.50%) to 9849.
Due later today are U.S. reports of the National Association of Realtors on pending home sales for May and The Federal Reserve Bank of Dallas Manufacturing Activity Index for June.
European indices are slightly up. On the statistical front, in the euro zone, June economic confidence index rose to 75.7 from 67.5 the previous month. It was expected to reach 80. In addition, the consumer confidence index was confirmed at -14.7 in June in a second reading compared to -18.8 in May. In the U.K., 9,300 home loans were granted in May against 25,000 expected and 15,900 (revised from 15,800) in April.
Asian indices ended lower. The Japanese Nikkei recorded the biggest decline with a 2.30% drop as official data showed that Japan's retail sales only rose 2.1% on month in May while +3.0% was expected. Over the weekend, government data showed that China's industrial profits grew 6.0% on year in May (-4.3% in April).
WTI Crude Oil futures are trading slightly higher despite a bearish opening and after a 0.6% decline last Friday, as sentiment was dragged down by the resurgence of coronavirus cases. Meanwhile, the total number of U.S. rigs slipped to 265 as of June 26 from 266 a week ago, and oil rigs in Canada fell to 13 from 17, according to Baker Hughes. The net long position of WTI crude oil increased 3.0% on week to 365,022 contracts as of June 23, reported the Commodities Futures Trading Commission.
Gold remains firm, close to a 8-year high while the US dollar consolidates as COVID-19 cases spike.
Gold rose 1.14 dollar (+0.06%) to 1772.44 dollars.
The EUR/USD rose 59pips to 1.1278.
US Equity Snapshot
Apple's (AAPL), app store rules that require app makers to use its payment system are being scrutinized by the U.S. Justice Department, reported Bloomberg.
Gilead Sciences (GILD), the biopharma, has set a price for remdesivir "for governments of developed countries of 390 dollars per vial. Based on current treatment patterns, the vast majority of patients are expected to receive a 5-day treatment course using 6 vials of remdesivir, which equates to 2,340 dollars per patient."
Boeing (BA), the aircraft maker, is gaining ground before hours as recertification flights for 737 MAX are beginning today.
Southwest Airlines (LUV) was upgraded to "buy" from "sell" at Goldman Sachs.
Beyond Meat (BYND), a producer of plant-based meat substitutes, was downgraded to "underweight" from "overweight" at Barclays.
Coty (COTY), the global beauty company, agreed to acquire a 20% stake in Kim Kardashian West's brand KKW for 200 million dollars, according to the Financial Times.
Source : TradingVIEW, Gain Capital
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.